摘要
目的:探讨肿瘤型M2丙酮酸激酶(TuM2-PK)在乳腺癌患者血中的表达水平及其临床应用价值。方法:用ELISA法分别检测52例乳腺癌、36例乳腺良性病变患者和60名健康体检者血浆中的TuM2-PK表达水平,并进行比较分析。结果:TuM2-PK在乳腺癌组阳性率为76.92%,乳腺良性病变组为16.67%,健康对照组为20.00%,乳腺癌组明显高于后两组(P<0.01),有淋巴结转移患者TuM2-PK阳性率(81.25%)高于无淋巴结转移患者(45.00%)(P<0.05)。结论:TuM2-PK对乳腺癌的辅助诊断有较高的临床价值,并对判断淋巴结转移及临床治疗具有一定的指导意义。
Objective: To investigate the expression and diagnostic values of tumor M2-PK(TuM2-PK) in breast cancer.Methods: The concentration of tumor M2-PK in plasma was detected by ELISA in 52 patients with breast cancer,36 patients with breast benign disease and 60 health controls.Results: TuM2-PK concentration in plasma and the positive rate were singificanfly higher in breast cancer(76.92%) than that in breast benign disease and in health controls(16.67% and 20.00%,respectively)(P〈0.01),TuM2-PK levels was higher in breast cancer patients with lymph node metastasis(81.25%) than that without metastasis(45.00%)(P〈0.05).Conclusion: The measurement of TuM2-PK is of great clinical value for the diagnosis of breast cancer,and is helpful in the evaluation of lymph node metastasis.
出处
《中国医药导报》
CAS
2010年第35期22-23,共2页
China Medical Herald